Thames Valley Cancer Network

Update in Myeloid Disorders & Haematology TSSG Meeting

at:   Oxford Belfry Hotel, Milton Common, Nr Thame, OX9 2JW.

on:   Monday 20th January 2014

TO SEE THE AVAILABLE PRESENTATIONS, CLICK ON THE RELEVANT TALK

PROGRAMME

  9.00 - 9.25: Registration and tea/coffee

Session 1.Advances in Clinical Management
Chairman: Dr Adam Mead (OUH, Oxford)
 
  9.25 - 9.30: Welcome and Review of the Day
Prof Paresh Vyas (OUH, Oxford)

  9.30 - 10.00: Blood transfusion trials: transfusing MDS patients
Dr Simon Stanworth (OUH, Oxford)

10.00 - 10.30: Genetic testing in myeloid disorders
Dr Angela Hamblin and Adam Burns (OUH, Oxford)

10.30 - 11.00: Low dose Cytarabine as non-intensive treatment for AML
in a patients over the age of 60. A review.

Dr Angharad Pryce (OUH, Oxford)
(substitution for the talk by Prof Mike Griffiths)

11.00: Coffee break

Session 2.The Future for Myeloid Disorders
Chairman: Dr Andy Peniket (OUH, Oxford)
 
11.30 - 12.00: New agents in AML trials: stem cell directed therapy
Prof Paresh Vyas (OUH, Oxford)

12.00 - 12.30: Transplantation for AML in 2014
Prof Charles Craddock (Birmingham)

12.30:Lunch

14.00:NSSG meeting
 
Approval has been granted by the Royal College of Pathologists for a maximum of 3 CPD points.
 
Please feel free to contact Bridget Watson for further information.

We would like to thank the companies listed below for their sponsorship of this meeting:
Click on the logo for a link to the company's web site.

     
     
       
   

Return to Home page